RISK FACTORS FOR NON-RESPONSE TO HORMONAL MEDICAL THERAPY IN PATIENTS WITH ENDOMETRIOSIS - Trial NCT06413381
Access comprehensive clinical trial information for NCT06413381 through Pure Global AI's free database. This phase not specified trial is sponsored by IRCCS Azienda Ospedaliero-Universitaria di Bologna and is currently Recruiting. The study focuses on Endometriosis. Target enrollment is 250 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Timeline & Enrollment
N/A
Apr 19, 2024
Nov 28, 2029
Primary Outcome
Rate of patients with endometriosis non-responsive to medical treatment at 12 months
Summary
Determine the proportion of patients with endometriosis unresponsive to medical therapy and
 to compare the clinical and ultrasonographic characteristics of this group of patients (study
 group) with the clinical and ultrasonographic characteristics of patients responsive to
 medical therapy (control group).
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06413381
Non-Device Trial